Showing results (171-180 of 199) with videos related to

Sort By:
Pageof 20
Wiener Klinische Wochenschrift|May 24, 1985
[Significance of hormone receptors of breast cancer cells for the duration of a disease-free interval]C C Zielinski, R Kuzmits, E Kubista, et al.
Strahlentherapie|November 1, 1975
[Pollen diet as an adjuvans of radiotherapy in gynecologic carcinomas]P Hernuss, E Müller Tyl, H Salzer, et al.
Infection|January 1, 2013
Which lumen is the source of catheter-related bloodstream infection in patients with multi-lumen central venous catheters?R Krause, T Valentin, H Salzer, et al.
Gynecologic Oncology|December 1, 1995
DNA amplification of HER-2/neu and INT-2 oncogenes in epithelial ovarian cancerM Medl, P Sevelda, K Czerwenka, et al.
British Journal of Cancer|March 1, 1994
A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancerA C Rosen, P Sevelda, M Klein, et al.
Anticancer Research|September 1, 1995
The influence of obesity on the disease-free survival in primary breast cancerA Obermair, C Kurz, E Hanzal, et al.
British Journal of Cancer|July 1, 1992
Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group study. Ondansetron Study GroupC Seynaeve, J Schuller, K Buser, et al.
Human Reproduction (Oxford, England)|September 20, 2012
Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequencesG Hudelist, N Fritzer, A Thomas, et al.
Geburtshilfe Und Frauenheilkunde|January 1, 1996
[Plasminogen activator inhibitor 1 and prognosis in breast carcinoma]K Mayerhofer, J Stolzlechner, S Yildiz, et al.
Oncology Reports|April 18, 2000
Significance of pretreatment serum hemoglobin and survival in epithelial ovarian cancerA Obermair, E Petru, G Windbichler, et al.
Pageof 20